By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$4.65
-$0.03
-0.64%
Last Update: 9 Sept 2025, 08:08
$2.62B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$3.02 - $11.68
52 Week Range

2576.HK Stock Price Chart

Explore Zhejiang Taimei Medical Technology Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2576.HK price movements and trends.

2576.HK Company Profile

Discover essential business fundamentals and corporate details for Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK) to support your stock research and investment decisions.

Sector

Technology

Industry

Software - Application

IPO Date

8 Oct 2024

Employees

627.00

CEO

Zhao Lu

Description

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial cooperation platform that optimizes clinical research operations management systems, as well as support decision-making with big data technology; eArchives, a clinical trial master file system; eCollect, an electronic data capture system; eCollege, a training management system; eQuality, an electronic quality audit system; eBalance, an interactive Web-based response system; eVisit Patient Reported Outcomes, a solution that enhances the ability of patients to enter data and the accuracy of clinical trial data; eTime, a project man-hour management system; and eImage, a medical image reading system. It also provides hospital software, including eTrial, a phase I ward management system; eSite, a clinical trial management system for GCP sites; GCP-X, an intelligent clinical trial platform; NomenCTMS, a clinical research project management system for GCP sites; eScreening, a subject information management and duplicate checking system; Intelligent Investigator, an initiated clinical trial platform; IIT-EDC, a clinical research data management platform; and Investigator-Initiated Clinical Trial Management System, a project management system. In addition, the company offers pharmacovigilance software solutions, such as eSafety global pharmacovigilance system; eSafety, an intelligent professional information system for pharmacovigilance; and SAE Manager, a safety data communication and management system for clinical trials. Further, it provides marketing software and digital innovation solutions. The company was founded in 2013 and is headquartered in Jiaxing, China.

2576.HK Financial Timeline

Browse a chronological timeline of Zhejiang Taimei Medical Technology Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

2576.HK Stock Performance

Access detailed 2576.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run